Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessio Cortellini

Showing results (41-50 of 257) with videos related to

Pageof 26
Sort By:
Frontiers in Oncology|July 2, 2026
Artificial intelligence-enabled liquid biopsy in cancer: a systematic review and meta- analysis of diagnostic performance and biological implicationsLuisana Sisca, Mariam Grazia Polito, Emy Sisca, et al.
Critical Reviews in Oncology/Hematology|December 20, 2025
To ablate or not to ablate? Outcomes of local ablative treatments (LAT) for oncogene addicted (OA) oligo-metastatic (OM) non-small cell lung cancer (NSCLC): A systematic reviewFabrizio Citarella, Cristina Fragale, Matteo Fiorenti, et al.
Journal of Clinical Neuromuscular Disease|November 16, 2018
Immune Checkpoint Inhibitors and Myasthenic Syndromes: A Case Report of a Metastatic Renal Cell Carcinoma Patient Treated With NivolumabAlessio Cortellini, Luca Napoleoni, Nicola Cimini, et al.
Expert Opinion on Biological Therapy|June 27, 2020
COVID-19 pneumonia and immune-related pneumonitis: critical issues on differential diagnosis, potential interactions, and managementMarco Russano, Fabrizio Citarella, Andrea Napolitano, et al.
Current Treatment Options in Oncology|August 23, 2021
Immunotherapy in Hepatocellular CarcinomaClaudia A M Fulgenzi, Thomas Talbot, Sam M Murray, et al.
Immunotherapy|February 13, 2020
Immunological insights on influenza infection and vaccination during immune checkpoint blockade in cancer patientsMelissa Bersanelli, Stefania Scala, Paola Affanni, et al.
Journal of Thoracic Disease|September 4, 2018
Where are we with treatment options after first line in small cell lung cancer?-report of two opposite cases treated with CAPTEM regimen and possible perspectivesAlessio Cortellini, Antonella Dal Mas, Katia Cannita, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 27, 2021
Knowledge and attitudes of Italian medical oncologists and palliative care physicians toward medical use of cannabis in cancer care: a national surveyMarco Filetti, Dario Trapani, Alessio Cortellini, et al.
The Lancet. Oncology|November 28, 2023
Treatment-related adverse events, including fatal toxicities, in patients with solid tumours receiving neoadjuvant and adjuvant immune checkpoint blockade: a systematic review and meta-analysis of randomised controlled trialsYu Fujiwara, Nobuyuki Horita, Elio Adib, et al.
Expert Opinion on Investigational Drugs|May 4, 2022
Novel immunotherapy combinations in clinical trials for hepatocellular carcinoma: will they shape the future treatment landscape?Claudia Angela Maria Fulgenzi, Antonio D'Alessio, Olabisi Ogunbiyi, et al.
Pageof 26

Showing results (41-50 of 257) with videos related to

Sort By:
Pageof 26
Frontiers in Oncology|July 2, 2026
Artificial intelligence-enabled liquid biopsy in cancer: a systematic review and meta- analysis of diagnostic performance and biological implicationsLuisana Sisca, Mariam Grazia Polito, Emy Sisca, et al.
Critical Reviews in Oncology/Hematology|December 20, 2025
To ablate or not to ablate? Outcomes of local ablative treatments (LAT) for oncogene addicted (OA) oligo-metastatic (OM) non-small cell lung cancer (NSCLC): A systematic reviewFabrizio Citarella, Cristina Fragale, Matteo Fiorenti, et al.
Journal of Clinical Neuromuscular Disease|November 16, 2018
Immune Checkpoint Inhibitors and Myasthenic Syndromes: A Case Report of a Metastatic Renal Cell Carcinoma Patient Treated With NivolumabAlessio Cortellini, Luca Napoleoni, Nicola Cimini, et al.
Expert Opinion on Biological Therapy|June 27, 2020
COVID-19 pneumonia and immune-related pneumonitis: critical issues on differential diagnosis, potential interactions, and managementMarco Russano, Fabrizio Citarella, Andrea Napolitano, et al.
Current Treatment Options in Oncology|August 23, 2021
Immunotherapy in Hepatocellular CarcinomaClaudia A M Fulgenzi, Thomas Talbot, Sam M Murray, et al.
Immunotherapy|February 13, 2020
Immunological insights on influenza infection and vaccination during immune checkpoint blockade in cancer patientsMelissa Bersanelli, Stefania Scala, Paola Affanni, et al.
Journal of Thoracic Disease|September 4, 2018
Where are we with treatment options after first line in small cell lung cancer?-report of two opposite cases treated with CAPTEM regimen and possible perspectivesAlessio Cortellini, Antonella Dal Mas, Katia Cannita, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 27, 2021
Knowledge and attitudes of Italian medical oncologists and palliative care physicians toward medical use of cannabis in cancer care: a national surveyMarco Filetti, Dario Trapani, Alessio Cortellini, et al.
The Lancet. Oncology|November 28, 2023
Treatment-related adverse events, including fatal toxicities, in patients with solid tumours receiving neoadjuvant and adjuvant immune checkpoint blockade: a systematic review and meta-analysis of randomised controlled trialsYu Fujiwara, Nobuyuki Horita, Elio Adib, et al.
Expert Opinion on Investigational Drugs|May 4, 2022
Novel immunotherapy combinations in clinical trials for hepatocellular carcinoma: will they shape the future treatment landscape?Claudia Angela Maria Fulgenzi, Antonio D'Alessio, Olabisi Ogunbiyi, et al.
Pageof 26